Beijing, Beijing, China In 2015 was created Purple Bull Startups, which is appeared as VC. The main department of described VC is located in the Beijing. The fund was located in Asia if to be more exact in China.
Speaking about the real fund results, this VC is 5 percentage points more often commits exit comparing to other organizations. The common things for fund are deals in the range of 5 - 10 millions dollars. The important activity for fund was in 2015. The fund is constantly included in less than 2 investment rounds annually.
The fund was created by Quanling Zhang.
The standard case for the fund is to invest in rounds with 2 partakers. Despite the Purple Bull Startups, startups are often financed by Shanghai Jindi Investment Management, Gaorong Capital. The meaningful sponsors for the fund in investment in the same round are Wacai.com, Sangel Capital, Plum Ventures. In the next rounds fund is usually obtained by We Capital, New Oriental Education & Technology, China Growth Capital.
Among the most popular portfolio startups of the fund, we may highlight Niangao-mama, Chic Yuanzui, Tianrang. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the most successful fund investment fields, there are E-Learning, Medical. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Cancer Research Technology | England, London, United Kingdom |
| Cheng Tian Capital II | China, Hong Kong, Hong Kong Island |
| Cushman & Wakefield | New York, New York, United States |
| Goel Fund | North Dakota, United States, Williston |
| Greyhound Capital | England, London, United Kingdom |
| Hamashin Lease | Hamamatsu, Japan, Shizuoka Prefecture |
| Kolibra Capital | Indonesia, Jakarta, Jakarta Raya |
| Momentum Bioscience | England, Reading, United Kingdom |
| New Capital Partners | Alabama, Birmingham, United States |
| Qianhai Wande Fund | China, Guangdong, Shenzhen |
| Qure | HaMerkaz, Israel, Netanya |
| RouteOne | Farmington Hills, Michigan, United States |
| Shenzhen Qianhai Ruize Capital Management | China, Fujian, Shanzhen |
| Siena Holdings | Plano, Texas, United States |
| Slome Capital | - |
| TBF Capital Group, LLC | Deerfield, Illinois, United States |
| Tecum Capital Partners | Pennsylvania, United States, Wexford |
| Tokuyama | Japan, Tokyo |
| Trigyn Technologies | - |
| Zhejiang Haining Yingchuang Equity Investment | China, Haining, Zhejiang |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Weimai Medical | $15M | 21 Sep 2023 | Wuxi Shi, Jiangsu, China | ||
Help Stem Cell Innovations | $25M | 15 Nov 2021 | Xuanwu District, Jiangsu, China | ||
Zhenzhi Yixue Keji | 29 Sep 2021 | Beijing, Beijing, China | |||
| 19 Apr 2021 | Gusu District, Jiangsu, China | ||||
Shanghai Shenzhi Information Technology | 11 Oct 2019 | Shanghai, China | |||
| 04 Apr 2019 | Futian District, Guangdong Province, China | ||||
Juvenile Get | 02 Apr 2019 | - | |||
Tianrang | $27M | 06 Aug 2018 | China, Shanghai | ||
BrainNow | 01 Jun 2018 | Futian District, Guangdong Province, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Weimai Medical | $15M | 21 Sep 2023 | Wuxi Shi, Jiangsu, China | ||
Help Stem Cell Innovations | $25M | 15 Nov 2021 | Xuanwu District, Jiangsu, China | ||
Zhenzhi Yixue Keji | 29 Sep 2021 | Beijing, Beijing, China | |||
| 19 Apr 2021 | Gusu District, Jiangsu, China | ||||
Shanghai Shenzhi Information Technology | 11 Oct 2019 | Shanghai, China | |||
| 04 Apr 2019 | Futian District, Guangdong Province, China | ||||
Juvenile Get | 02 Apr 2019 | - | |||
Tianrang | $27M | 06 Aug 2018 | China, Shanghai | ||
BrainNow | 01 Jun 2018 | Futian District, Guangdong Province, China |
